Inflammation of the pancreas (pancreatitis) Gallbladder problems Hypoglycemia Gastrointestinal reactions Kidney issues Mood changes A personal or family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 A known allergy or hypersensitivity to either medication or any of its ingredients Because of potential risks to the baby, neither medication is recommended during pregnancy, nor are they recommended for people with severe stomach issues like gastroparesis, says So
About the Experts Janese Laster, M.D., is board-certified in internal medicine, gastroenterology, obesity medicine, and nutrition at Georgetown University Hospital
Summary Hims expects $2.3-2.4 billion in revenue for 2025, with $725 million from weight loss The decision to continue compounding semaglutide (GLP-1s) is controversial given the FDA has declared the shortage over Hims is likely operating within the law and should be able to defend itself against potential FDA actions and third-party litigation On February 24, 2025, Hims & Hers Health, Inc
Your disease-modifying medications remain the primary treatment for lupus inflammation
Missing doses or not following the instructions can reduce how well the pill works
